55
Participants
Start Date
July 8, 2020
Primary Completion Date
September 1, 2021
Study Completion Date
September 1, 2021
Convalescent Plasma with antibody against SARS-CoV-2.
"Convalescent plasma plus standard treatment for COVID-19. The convalescent plasma is from patients recovered from COVID-19 and negative viremia in the test detection COVID-19.~The infusions will be given on days 1 and 2, of the study, after the positive result for COVID-19 of the recipient patient."
Standard treatment for COVID-19
The patients will receive the standard treatment for COVID-19, according to guidelines for COVID-19 (retrovirals drugs, interferon-α / β, anti-Interleukin-6 monoclonal antibody, oxygen therapy, etc..)
University Hospital Son Llatzer, Palma de Mallorca
Fundació d'investigació Sanitària de les Illes Balears
OTHER_GOV
Hospital Son Llatzer
OTHER